Loading chat...
US HB6958
Bill
Status
Introduced
9/27/2018
Primary Sponsor
Francis Rooney
Click for details
AI Summary
Legislative Description
Drug Price Transparency Act
Congressional oversight
Last Action
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
9/27/2018
Committee Referrals
Energy And Commerce9/27/2018
Full Bill Text
No bill text available